ARX vs BIREF: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
ARX is the larger of the two ($4.32B market cap): the incumbent the market prices for continued execution (21.35x forward earnings). BIREF is the smaller challenger ($1.30B): more room to run, but more to prove. If you believe in growth, ARX fits: analysts expect its revenue to rise 10% next year, against a 3% decline for BIREF. If you believe BIREF's main driver (Full plants and a lower cost per unit) matters more than the growth gap, BIREF fits.
ARX vs BIREF: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ARX | BIREF | What it tells you |
|---|---|---|---|
| Market cap | $4.32B | $1.30B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Trailing P/E | 27.60 | 14.81 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Price vs 52-week range | 100% of range | 35% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 5.90 | 0.79 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how ARX and BIREF affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARX and BIREF share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARX and BIREF exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Accelerant Holdings (ARX) do?
Accelerant Holdings operates a data-driven risk exchange for specialty insurance. On one side are managing general agents (MGAs), the specialist underwriters who design and sell niche insurance products; on the other are risk capital partners such as insurers, reinsurers, and institutional investors who put up the capital to back those policies. Accelerant sits in the middle, using proprietary technology, data, and machine learning to match risk with capital, share high-fidelity underwriting data, and monitor portfolios. It earns a fixed-percentage, volume-based fee for sourcing, managing, and monitoring the business written through the exchange, which spans more than 500 specialty insurance products across 22 countries. The company reports through three segments: Exchange Services, MGA Operations, and Underwriting, and describes its model as capital-light because it aims to retain only a small share of the premium risk (roughly 9% in 2025) and pass the rest to third-party capital.
What does Birchcliff Energy (BIREF) do?
Birchcliff Energy Ltd. is an intermediate oil and natural gas producer headquartered in Calgary, with essentially all of its production in the Montney formation of the Peace River Arch in northwestern Alberta. Its main asset is the Greater Pouce area around Pouce Coupe and Gordondale, where it owns and operates the Pouce Coupe gas plant, and it has a second, less developed position at Elmworth further south. Production is about 84% natural gas and 16% liquids (light oil, condensate and natural gas liquids). The company trades on the Toronto Stock Exchange as BIR and reports in Canadian dollars; BIREF is the US OTC quote of the same shares, priced in US dollars at roughly the TSX price divided by the exchange rate.
ARX vs BIREF: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- ARX drivers: The Thoma Bravo deal sets the price; Go-shop ended with no rival bid.
- BIREF drivers: Full plants and a lower cost per unit; Market diversification beyond AECO.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: With a signed all-cash agreement, the main risk is deal completion. For BIREF, commodity prices are the dominant risk.
ARX or BIREF: which should you pick?
If the story you believe is ARX's (The Thoma Bravo deal sets the price), ARX is the more direct way to own it; if it is BIREF's (Full plants and a lower cost per unit), BIREF is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARX and BIREF guides.
ARX vs BIREF: the full fundamentals
ARX. Since August 13, 2026 ARX has been valued by the Thoma Bravo offer, not by earnings multiples. At $19.88 the shares trade about 1.9% below the $20.25 cash price, a spread that reflects the time until the expected first-half 2027 close and the chance the deal does not complete. TTM net income has turned positive (about $61 million) now that the 2025 IPO charge has rolled out of the trailing year, and measures such as about 4 times TTM sales or 21 times forward earnings describe what the buyer is paying rather than where the stock is likely to trade before closing.
BIREF. Company figures are in Canadian dollars; BIREF trades in US dollars at roughly the TSX price divided by the CAD/USD rate. On trailing numbers the enterprise value trades near 4.1 times EBITDA and the shares near 0.8 times book, low next to many US gas producers but typical for AECO-exposed Canadian peers. Q3 2026 results beat the prior quarter on every operating line and lifted full-year guidance, yet the shares are down about 12% this year, so the valuation leans on the gas-price outlook and on how much the Goodfare plant will cost.
Headline figures (approximate, November 2026): ARX shows deal price (thoma bravo, all cash) $20.25 per share; enterprise value >$4 billion, share price / spread to deal $19.88 (Nov 20, 2026) / ~1.9%, expected close First half of 2027, revenue (ttm) ~$1.08 billion; BIREF shows share price (biref, us otc) ~US$4.74 (YTD ~-12%), market cap ~US$1.3B, q3 2026 production ~86,073 boe/d (up ~7% YoY), q3 2026 adjusted funds flow ~C$103.6M (C$0.38/share, up ~19%).
The bottom line: ARX vs BIREF
ARX and BIREF are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ARX and BIREF exposure against your real portfolio. It is not an investment adviser.
Wondering how ARX or BIREF fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Accelerant Holdings
Ask Walnut's AI anything about ARX and see how it fits what you own.
FAQ
What is the difference between ARX and BIREF?
+
Accelerant Holdings operates a data-driven risk exchange for specialty insurance. Birchcliff Energy Ltd. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ARX or BIREF the better stock?
+
Neither is universally better. ARX is the larger incumbent; BIREF is the smaller challenger. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ARX or BIREF?
+
A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ARX and BIREF?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ARX vs BIREF?
+
ARX: With a signed all-cash agreement, the main risk is deal completion. Shareholder approval, regulatory approvals for an insurance business, financing and other conditions could delay or block the transaction, and the expected close in the first half of 2027 leaves months for something to change. If the deal failed, the stock would likely fall back toward a price set by fundamentals; it traded near $13 in July 2026, before the announcement-day jump of about 43%. The upside is capped near $20.25 unless a higher bid appears, and the go-shop ended without one. Holders also bear the time value of waiting: a roughly 1.9% spread over several months is a modest return for that risk. An insider sale of about $6.5 million was disclosed in November 2026. The underlying business risks still apply to a broken-deal scenario: a capital-light model unproven across a full insurance cycle, dependence on keeping MGAs and capital partners engaged, a large 2025 net loss tied to the IPO, slower revenue growth in Q3 2026, and cyclical specialty insurance pricing. BIREF: Commodity prices are the dominant risk. About 84% of production is natural gas, and around 45% of that is still sold at AECO, a hub that has repeatedly traded near or below C$2/GJ when Western Canadian supply outran pipeline and LNG capacity. Management's own sensitivities show free funds flow moving several million dollars for every small change in gas prices, and 2026 free funds flow of ~C$105M is thin relative to the equity value, so a weak winter could erase much of it. Liquids pricing matters too. Second, growth beyond ~90,000 boe/d needs new processing capacity, and the Goodfare plant would add C$150M to C$170M of 2027 capital spending and execution risk just as debt is coming down; if FID is positive, 2027 free funds flow could shrink. Third, the dividend was cut from C$0.80 to C$0.12 a year in 2024, which shows payouts depend on prices. Other risks include Alberta royalty and carbon policy, wildfire or plant outages (a single turnaround removed ~6,900 boe/d in Q2 2026), and currency: BIREF holders receive a Canadian dividend converted to US dollars and may face Canadian withholding tax. OTC liquidity is also thinner than on the TSX, so spreads can be wider, and the shares have fallen about 12% in 2026 despite three guidance increases.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ARX or BIREF; figures are approximate and dated (as of November 2026). Verify current data before investing.